Attached files
| file | filename |
|---|---|
| EX-3.1 - EX-3.1 - NEOGENOMICS INC | neocharter-exhibit31.htm |
| EX-10.18 - EX-10.18 - NEOGENOMICS INC | neoexhibit1018kmckenzi.htm |
| EX-21.1 - EX-21.1 - NEOGENOMICS INC | neoexhibit21112312019.htm |
| EX-31.1 - EX-31.1 - NEOGENOMICS INC | neoexhibit31112312019.htm |
| EX-31.2 - EX-31.2 - NEOGENOMICS INC | neoexhibit31212312019.htm |
| EX-32.1 - EX-32.1 - NEOGENOMICS INC | neoexhibit32112312019.htm |
| EX-23.1 - EX-23.1 - NEOGENOMICS INC | neoexhibit23112312019.htm |
| EX-4.1 - EX-4.1 - NEOGENOMICS INC | neoexhibit41descriptio.htm |
| 10-K - 10-K - NEOGENOMICS INC | neo-20191231.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-205906, 333-125994, 333-139484, 333-159749, 333-173494, 333-180095, 333-189391, 333-210402 on Form S-8, Registration Statement Nos. 333-186067, 333-212099, 333-155784, and 333-166526 on Form S-3, and Registration Statement Nos. 333-228743 and 333-231608 on Form S-3ASR of NeoGenomics, Inc. of our report dated February 26, 2019 relating to the consolidated financial statements as of and for each of the years in the two-year period ended December 31, 2018, appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Crowe LLP
Indianapolis, Indiana
February 28, 2020